Identification of Potential Metabolic Markers of Hypertension in Chinese Children

Jiahong Sun1, Min Zhao2, Liu Yang1

  • 1Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

Insights

This study identified key serum metabolites in children with hypertension. Ethanolamine and 2-methyl-3-hydroxy-5-formylpyridine-4-carboxylate show promise for diagnosing pediatric hypertension.

Area of Science:

  • Pediatric cardiovascular health
  • Metabolomics
  • Biomarker discovery

Background:

  • Adult hypertension is linked to various metabolic pathways.
  • Pediatric hypertension's metabolic associations remain understudied.
  • This study investigates serum metabolite differences in hypertensive children.

Purpose of the Study:

  • To identify differential serum metabolites in children with and without hypertension.
  • To explore potential metabolic pathways associated with pediatric hypertension.
  • To discover novel biomarkers for early detection of hypertension in children.

Main Methods:

  • Untargeted metabolomics using ultrahigh-performance liquid chromatography-quadrupole time-of-flight-mass spectrometry.
  • Analysis of serum samples from 26 hypertensive and 26 normotensive children (aged 6-11 years).
  • Logistic regression and pathway analysis (KEGG, MetaboAnalyst) to identify significant metabolites and pathways.

Main Results:

  • Identified differential metabolites primarily in amino acid and glycerophospholipid metabolism.
  • Two metabolites, ethanolamine and 2-methyl-3-hydroxy-5-formylpyridine-4-carboxylate, were significantly associated with hypertension.
  • These two metabolites demonstrated good discriminative ability (AUC 0.820) for identifying hypertensive children.

Conclusions:

  • Untargeted metabolomics effectively revealed distinct serum metabolite profiles in pediatric hypertension.
  • Ethanolamine and 2-methyl-3-hydroxy-5-formylpyridine-4-carboxylate show potential as diagnostic biomarkers for pediatric hypertension.
  • Findings provide new insights into the metabolic underpinnings of hypertension in children.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
108
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
267
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
179
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K